Page last updated: 2024-09-05

orantinib and amg 900

orantinib has been researched along with amg 900 in 2 studies

Compound Research Comparison

Studies
(orantinib)
Trials
(orantinib)
Recent Studies (post-2010)
(orantinib)
Studies
(amg 900)
Trials
(amg 900)
Recent Studies (post-2010) (amg 900)
110193632230

Protein Interaction Comparison

ProteinTaxonomyorantinib (IC50)amg 900 (IC50)
Aurora kinase AHomo sapiens (human)0.005
Aurora kinase BHomo sapiens (human)0.004
Aurora kinase CHomo sapiens (human)0.001

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhatt, HG; Borisa, AC1
Aiche, S; Bassermann, F; Becker, W; Canevari, G; Casale, E; Depaolini, SR; Ehrlich, HC; Felder, ER; Feuchtinger, A; Garz, AK; Gohlke, BO; Götze, K; Greif, PA; Hahne, H; Heinzlmeir, S; Helm, D; Huenges, J; Jeremias, I; Kayser, G; Klaeger, S; Koch, H; Koenig, PA; Kramer, K; Kuster, B; Médard, G; Meng, C; Petzoldt, S; Polzer, H; Preissner, R; Qiao, H; Reinecke, M; Reiter, K; Rueckert, L; Ruland, J; Ruprecht, B; Schlegl, J; Schmidt, T; Schneider, S; Schoof, M; Spiekermann, K; Tõnisson, N; Vick, B; Vooder, T; Walch, A; Wilhelm, M; Wu, Z; Zecha, J; Zolg, DP1

Reviews

1 review(s) available for orantinib and amg 900

ArticleYear
A comprehensive review on Aurora kinase: Small molecule inhibitors and clinical trial studies.
    European journal of medicinal chemistry, 2017, Nov-10, Volume: 140

    Topics: Animals; Antineoplastic Agents; Aurora Kinases; Cell Proliferation; Clinical Trials as Topic; Humans; Molecular Structure; Protein Kinase Inhibitors; Small Molecule Libraries

2017

Other Studies

1 other study(ies) available for orantinib and amg 900

ArticleYear
The target landscape of clinical kinase drugs.
    Science (New York, N.Y.), 2017, 12-01, Volume: 358, Issue:6367

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cytokines; Drug Discovery; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Mice; Molecular Targeted Therapy; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proteomics; Xenograft Model Antitumor Assays

2017